drs. J.C. (Jannet) Beukema

E-mail:
j.c.beukema umcg.nl

Research

  1. 2020
  2. 2019
  3. 2018
  4. Noordman, B. J., Verdam, M. G. E., Lagarde, S. M., Hulshof, M. C. C. M., van Hagen, P., Henegouwen, M. I. V. B., ... van Lanschot, J. J. B. (2018). Effect of Neoadjuvant Chemoradiotherapy on Health-Related Quality of Life in Esophageal or Junctional Cancer: Results From the Randomized CROSS Trial. Journal of Clinical Oncology, 36(3), 268-279. https://doi.org/10.1200/JCO.2017.73.7718
  5. 2017
  6. 2015
  7. Shapiro, J., Van Lanschot, J. J. B., Hulshof, M. C. C. M., van Hagen, P., Henegouwen, M. I. V. B., Wijnhoven, B. P. L., ... CROSS Study Grp (2015). Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncology, 16(9), 1090-1098. https://doi.org/10.1016/S1470-2045(15)00040-6
  8. 2014
  9. Oppedijk, V., van der Gaast, A., van Lanschot, J. J. B., van Hagen, P., van Os, R., van Rij, C. M., ... Hulshof, M. C. C. M. (2014). Patterns of Recurrence After Surgery Alone Versus Preoperative Chemoradiotherapy and Surgery in the CROSS Trials. Journal of Clinical Oncology, 32(5), 385-391. https://doi.org/10.1200/JCO.2013.51.2186
  10. 2013
  11. 2012
  12. van Hagen, P., van Lanschot, J. J. B., Steyerberg, E. W., Henegouwen, M. I. V. B., Wijnhoven, B. P. L., Richel, D. J., ... Hulshof, M. C. C. M. (2012). Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer. New England Journal of Medicine, 366(22), 2074-2084.
  13. Nijkamp, J., de Haas-Kock, D. F. M., Beukema, J. C., Neelis, K. J., Woutersen, D., Ceha, H., ... Marijnen, C. A. M. (2012). Target volume delineation variation in radiotherapy for early stage rectal cancer in the Netherlands. Radiotherapy and Oncology, 102(1), 14-21. https://doi.org/10.1016/j.radonc.2011.08.011
  14. 2011
  15. 2010
  16. 2009
  17. 1994

ID: 440400